Company Description
Cencora, Inc. sources and distributes pharmaceutical products.
The company’s U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.
This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics.
Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry.
The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023.
Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
| Country | United States |
| Founded | 2001 |
| Industry | Medical Distribution |
| Sector | Healthcare |
| Employees | 46,000 |
| CEO | Robert Mauch |
Contact Details
Address: 1 West First Avenue Conshohocken, Pennsylvania 19428-1800 United States | |
| Phone | 610 727 7000 |
| Website | cencora.com |
Stock Details
| Ticker Symbol | COR |
| Exchange | NYSE |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0001140859 |
| CUSIP Number | 03090BBJ8 |
| ISIN Number | US03073E1055 |
| Employer ID | 23-3079390 |
| SIC Code | 5122 |
Key Executives
| Name | Position |
|---|---|
| Dr. Robert P. Mauch Ph.D., PharmD | President, Chief Executive Officer, Chief Operating Officer, Executive Vice President and Director |
| Steven H. Collis | Executive Chairman |
| James F. Cleary Jr. | Executive Vice President and Chief Financial Officer |
| Lazarus Krikorian | Senior Vice President, Chief Accounting Officer and Corporate Controller |
| Pawan Singh Verma | Executive Vice President, Chief Data and Information Officer |
| Bennett S. Murphy | Senior Vice President of Investor Relations |
| Jennifer E. Dubas | Senior Vice President and Chief Compliance Officer |
| Silvana Battaglia | Executive Vice President and Chief Human Resources Officer |
| Richard Tremonte | Executive Vice President and President of U.S. Pharmaceuticals |
| Ann Anaya | Senior Vice President and Chief Diversity Equity and Inclusion Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 19, 2024 | 144 | Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 8, 2024 | 8-K | Current Report |
| Nov 6, 2024 | 8-K | Current Report |
| Oct 22, 2024 | 144 | Filing |
| Oct 15, 2024 | 8-K | Current Report |
| Sep 17, 2024 | 144 | Filing |
| Sep 17, 2024 | 144 | Filing |
| Sep 5, 2024 | 8-K | Current Report |
| Aug 20, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |